lululemon athletica Free cash flow increased by 453.8% to $959.67M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 17.7%, from $1.17B to $959.67M. Over 3 years (FY 2021 to FY 2024), Free cash flow shows an upward trend with a 16.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $149.88M | $205.39M | $35.86M | $603.47M | -$354.61M | -$47.08M | -$109.79M | $839.28M | -$91.44M | $331.20M | $226.95M | $1.18B | -$3.16M | $298.05M | $122.18M | $1.17B | -$271.22M | $959.67M |
| QoQ Change | — | +37.0% | -82.5% | >999% | -158.8% | +86.7% | -133.2% | +864.4% | -110.9% | +462.2% | -31.5% | +418.9% | -100.3% | >999% | -59.0% | +854.7% | -123.3% | +453.8% |
| YoY Change | — | — | — | — | -336.6% | -122.9% | -406.2% | +39.1% | +74.2% | +803.5% | +306.7% | +40.3% | +96.5% | -10.0% | -46.2% | -0.9% | <-999% | -17.7% |